HomeMedical DevicesIn-Vitro Diagnostics

In-Vitro Diagnostics Market Research Reports & Consulting

discount on Mnm

Market Reports


Title Published Price TOC Available

Urinalysis Market by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) - Forecast to 2021

The global urinalysis market is expected to reach USD 1.91 Billion by 2021 from USD 1.32 Billion in 2016, at a CAGR of 7.6%. The global urinalysis market is broadly classified into product type, test type, applications, and end user categories. The key players in the urinalysis market include Beckman Coulter (U.S.), Roche Diagnostics (Switzerland), Siemens AG (Germany), Sysmex (Japan) and Arkray, Inc. (Japan).

July 2016 $ 5650 selected

Blood Culture Tests Market by Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia) & End User (Hospital Laboratories, Reference Laboratories) - Global Forecast to 2021

The blood culture tests market is projected to reach USD 4,768.9 Million by 2021 from USD 3,252.6 Million in 2016, growing at a CAGR of 8.0%. Major factors driving the growth of this market are rapidly rising aging population, increase in product approvals and launches, growing number of sepsis cases and high cost of treatment, high incidence of bloodstream infections, increase in demand for rapid diagnostic techniques, and high prevalence of infectious diseases. On the other hand, factors such as high cost of automated instruments and lack of technically skilled professionals are likely to hinder market growth.

July 2016 $ 5650 selected

Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based - Global Forecast to 2021

The point-of-care diagnostics market is expected to reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, at a CAGR of 9.8% during the forecast period. Rise in the prevalence of lifestyle and infectious diseases and the increasing inclination towards home healthcare across the globe are key factors fueling the growth of the point-of-care diagnostics market across the globe. Private investments and venture funding towards the development of new products along with the growing government support to increase the adoption of POC devices are boosting market growth. However, pricing pressures owing to reimbursement cuts and budget constraints hampering profits of these devices is restraining the growth of this market.

July 2016 $ 5650 selected

Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), Allergen (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End User (Hospital, Diagnostic Laboratory) - Forecast to 2021

The global allergy diagnostics market is expected to reach USD 5.34 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 12.4%. The global allergy diagnostics market is broadly classified by product, test, allergen, end user, and region. On the basis of products, the allergy diagnostics market is segmented into assay kits, instruments, and services. The assay kits segment is expected to account for the largest share of the global allergy diagnostics market in 2016.

June 2016 $ 5650 selected

Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021

The global clinical microbiology market is projected to reach USD 5.77 Billion by 2021 from USD 3.35 Billion in 2016, growing at a CAGR of 11.5% from 2016 to 2021. Market growth can be attributed to factors such as technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science researches.

June 2016 $ 5650 selected

HLA Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sangerís Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021

The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantations; and increased funding, research grants, and public-private investments.

May 2016 $ 5650 selected

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020

The molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. In this report, the molecular diagnostics market is broadly segmented on the basis of technologies, applications, products & services, and end users. On the basis of technology, the market is segmented into PCR, INAAT, microarrays, hybridization, DNA sequencing and next-generation sequencing (NGS), and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate.

November 2015 $ 5650 selected

Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020

Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.

October 2015 $ 5650 selected

In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020

The global IVD market is expected to reach USD 75.1 Billion by 2020, at a CAGR of 5.8% from 2015 to 2020. The global IVD market has evolved over the years with launch of number of innovative techniques having applications across multiple therapeutic areas. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases across the globe, growing aging population, and increasing usage of point-of-care testing and personalized medicine. Moreover, a new range of condition-specific markers and tests with advances in genomics and proteomics and increasing investment in emerging countries are creating new opportunities for this market. However, inadequate reimbursement and stringent regulatory approval framework are restraining the growth of this market.

July 2015 $ 5650 selected

Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019

The global hemostasis/coagulation analyzer market is expected to reach $3.58 billion by 2019 from $2.4 billion in 2014, growing at a CAGR of 8.3% from 2014 to 2019. Hemostasis products comprise analyzers and reagents which are used to diagnose blood-related disorders. In the past ten years, the global hemostasis market has witnessed challenging and dynamic market conditions due to the presence of high competition amongst market players, development of technologically advanced instruments and reagents, and increasing healthcare awareness amongst the population globally.

March 2015 $ 5650 selected

Drug Screening Market by Products and Services (Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents), Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat) - Global Forecast To 2019

The drug screening market size, in terms of value, is expected to reach $6.3 billion by 2019 from $4 billion in 2014, at a CAGR of 9.5%. Major factors driving the growth of this market include high usage of alcohol, prescribed drugs and illicit drugs, growing aging population that leads to increased use of alcohol and prescription drug use, funding by the U.S. federal governments for drug testing, enactment of stringent laws in developed countries, and growing awareness for drug testing in developing nations. However, privacy rights in some countries may hinder the growth of this market. In such countries, drug and alcohol testing may be seen as a violation of an individualís rights to privacy. Emerging economies such as India, China, and Brazil present an array of opportunities for this market.

March 2015 $ 5650 selected

Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019

The blood screening market is expected to reach $2.54 billion by 2019 from $1.55 billion in 2014, at a CAGR of 10.4%. High growth in this market can be attributed to the increasing number of blood donations and blood donors, rising awareness regarding safety of donated blood, increasing affordability to pay for NAT-tested blood, increasing adoption rate for NAT testing, growing demand for donated blood, and increasing prevalence/incidence of infectious diseases.

March 2015 $ 5650 selected

Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019

The global clinical chemistry analyzers market was valued at $8,965.00 million in 2014and is poised to grow at a CAGR of 5.52% between 2014and 2019, to reach $11,728.01 million in 2018.Rapid growth in the diagnostics market, increase in the healthcare spending, and increasing incidence in lifestyle disease will drive the growth of the clinical chemistry analyzers market. Furthermore, increasing awareness for preventative healthcare, increase in aging population, increase in reagent rental agreements and increasing demand for laboratory automation will aid the demand for clinical chemistry analyzers products.

October 2014 $ 5650 selected

Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019

The global hematology analyzers and reagents market is estimated to grow at a CAGR of 5.2% from 2014 to 2019. Technological developments in high throughput hematology analyzers, integrationof basic flow-cytometry techniques in modern hematology analyzers, increasingadoption of automated hematology instruments by diagnostic laboratories, technological advancements, and developments in the high sensitivity point-of-care (POC) hematology testing are some of the key factors that are fuelling the growth of the hematology market.

May 2014 $ 5650 selected



Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us


Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support



US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



M&M Custom Research Services provides clients with the information on their business scenario required to stay ahead of competition in today's fast paced business environment.
'Connect With Us

Call us at: 1-888-600-6441
Live Chat Support


Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo